ECL Stock Analysis — Ecolab
Sector: Industrials
AI Verdict
Ecolab trades at 32x next year's earnings while analysts expect 15.7% EPS growth—you're paying a premium the numbers don't yet support, but the moat in mission-critical hygiene solutions makes the growth more credible than most industrials.
Competitive Moat
Ecolab dominates water, hygiene, and infection prevention solutions for industrial and institutional clients, with sticky long-term contracts and deep integration into customer operations. Its moat comes from proprietary chemical formulas and service expertise that make switching costly and risky for clients, especially in regulated industries.
Summary
Ecolab's premium valuation hinges on its ability to convert incremental revenue growth into double-digit earnings gains.
Where It Stands
Ecolab returned 13.16% over the last year, trades at 32.0x forward earnings versus the industrials median of 20x, and its RSI of 59.3 signals neutral momentum.
Key Metrics
- RSI: 59.3 — Neutral
- Trailing P/E: 37.0x
- Forward P/E: 32.0x
- PEG Ratio: 2.36
- Earnings Growth: +0.2%
- Revenue Growth: +0.0%
- Market Cap: $76.1B
- Dividend Yield: 0.01%
- 1-Year Return: 13.16%
- 52-Week High: $309.27
- 52-Week Low: $235.62
Analyst Consensus
20 Buy · 11 Hold · 0 Sell (31 analysts)
Bull Case
With analysts expecting 15.7% EPS growth next year, Ecolab's 32.0x forward P/E reflects optimism that its recurring service model will keep delivering profit gains.
Bear Case
A P/E compression from 32.0x to the sector median of 20x would wipe out over a third of the stock's value even if earnings meet expectations.
Catalyst to Watch
Watch for new contract wins or regulatory changes in hygiene standards, as these could accelerate or stall Ecolab's earnings trajectory.